Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1994. Upgrade now.
Date Value
December 31, 2023 -20.03M
September 30, 2023 -22.86M
June 30, 2023 0.086M
March 31, 2023 3.119M
December 31, 2022 -0.794M
September 30, 2022 10.69M
June 30, 2022 5.659M
March 31, 2022 -6.563M
December 31, 2021 6.176M
September 30, 2021 9.043M
June 30, 2021 29.32M
March 31, 2021 82.04M
December 31, 2020 71.71M
September 30, 2020 89.16M
June 30, 2020 91.12M
March 31, 2020 43.72M
December 31, 2019 45.71M
September 30, 2019 20.45M
June 30, 2019 20.00M
March 31, 2019 16.55M
December 31, 2018 14.66M
September 30, 2018 14.32M
June 30, 2018 665.88M
March 31, 2018 670.84M
December 31, 2017 690.21M
Date Value
September 30, 2017 686.34M
June 30, 2017 39.47M
March 31, 2017 56.70M
December 31, 2016 44.62M
September 30, 2016 52.06M
June 30, 2016 58.54M
March 31, 2016 61.94M
December 31, 2015 84.74M
September 30, 2015 106.56M
June 30, 2015 99.59M
March 31, 2015 81.21M
December 31, 2014 93.06M
September 30, 2014 294.89M
June 30, 2014 315.12M
March 31, 2014 302.35M
December 31, 2013 275.59M
September 30, 2013 52.14M
June 30, 2013 34.18M
March 31, 2013 52.07M
December 31, 2012 47.71M
September 30, 2012 41.98M
June 30, 2012 34.14M
March 31, 2012 28.76M
December 31, 2011 19.47M
September 30, 2011 21.26M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-22.86M
Minimum
Sep 2023
91.12M
Maximum
Jun 2020
25.15M
Average
10.69M
Median
Sep 2022

Cash from Financing (TTM) Benchmarks

Novartis AG -14.28B
MorphoSys AG --
Illumina Inc -1.21B
Biogen Inc 149.30M
Pfizer Inc 26.07B